{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T04:08:14Z","timestamp":1745467694690,"version":"3.40.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"crossref"}]},{"name":"World Health Organization Thailand"},{"name":"Center of disease control foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"DOI":"10.1186\/s12875-025-02824-y","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:16:08Z","timestamp":1745392568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Costs of the HEARTS hypertension program in primary care in Lampang province, Thailand"],"prefix":"10.1186","volume":"26","author":[{"given":"Piyachon","family":"Aramrat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanchanok","family":"Aramrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas Taeksung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Jami","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumava","family":"Basu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saudamini","family":"Dabak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanrudee","family":"Isaranuwatchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nutchar","family":"Wiwatkunupakarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apichard","family":"Sukonthasarn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaisiri","family":"Angkurawaranon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deliana","family":"Kostova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"10226","key":"2824_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795\u2013808.","journal-title":"Lancet"},{"key":"2824_CR2","first-page":"346","volume-title":"Thai National health examination survey (NHES) VI","author":"W Aekplakorn","year":"2021","unstructured":"Aekplakorn W. Thai National health examination survey (NHES) VI. Bangkok: Health Systems Research Institue (HSRI); 2021. p. 346."},{"issue":"10","key":"2824_CR3","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.puhe.2014.08.003","volume":"128","author":"C Angkurawaranon","year":"2014","unstructured":"Angkurawaranon C, Jiraporncharoen W, Chenthanakij B, Doyle P, Nitsch D. Urbanization and non-communicable disease in Southeast Asia: a review of current evidence. Public Health. 2014;128(10):886\u201395.","journal-title":"Public Health"},{"key":"2824_CR4","first-page":"60","volume-title":"Hypertension care in Thailand: best practices and challenges, 2019","author":"SSS Wattanayingcharoenchai","year":"2019","unstructured":"Wattanayingcharoenchai SSS, Tangsawad S, Pitayarangsarit S, Angkurawaranon C, Sukonthasarn A, et al. Hypertension care in Thailand: best practices and challenges, 2019. Bangkok: World Health Organization, Country Office for Thailand; 2019. p. 60."},{"issue":"6","key":"2824_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1108\/JHR-11-2018-085","volume":"32","author":"NTS Woodham","year":"2018","unstructured":"Woodham NTS, Somrongthong R, Auamkul N. Medication adherence and associated factors among elderly hypertension patients with uncontrolled blood pressure in rural area, Northeast Thailand. J Health Res. 2018;32(6):449\u201358.","journal-title":"J Health Res"},{"issue":"1","key":"2824_CR6","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1186\/s12913-020-05719-z","volume":"20","author":"N Charoensab","year":"2020","unstructured":"Charoensab N, Pinyopornpanish K, Thangsuk P, Jiraporncharoen W, Angkurawaranon C. Lowered blood pressure targets identify new, uncontrolled hypertensive cases: patient characteristics and implications for services in Thailand. BMC Health Serv Res. 2020;20(1):869.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2824_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/jch.14193","volume":"23","author":"C Angkurawaranon","year":"2021","unstructured":"Angkurawaranon C, Pinyopornpanish K, Srivanichakorn S, Sanchaisuriya P, Thepthien BO, Tooprakai D, et al. Clinical audit of adherence to hypertension treatment guideline and control rates in hospitals of different sizes in Thailand. J Clin Hypertens (Greenwich). 2021;23(4):702\u201312.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2824_CR8","first-page":"73","volume-title":"Technical package for cardiovascular disease management in primary health care","author":"Hearts","year":"2016","unstructured":"Hearts. Technical package for cardiovascular disease management in primary health care. Geneva: World Health Organization; 2016. p. 73."},{"key":"2824_CR9","volume-title":"Improving hypertension control in 3 million people: country experiences of programme development and implementation","author":"WHO","year":"2020","unstructured":"WHO. Improving hypertension control in 3 million people: country experiences of programme development and implementation. Geneva: World Health Organization; 2020."},{"issue":"4","key":"2824_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/jch.14141","volume":"23","author":"P Kaur","year":"2021","unstructured":"Kaur P, Kunwar A, Sharma M, Mitra J, Das C, Swasticharan L, et al. India hypertension control Initiative-Hypertension treatment and blood pressure control in a cohort in 24 Sentinel site clinics. J Clin Hypertens (Greenwich). 2021;23(4):720\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"2824_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jch.13814","volume":"22","author":"Y Valdes Gonzalez","year":"2020","unstructured":"Valdes Gonzalez Y, Campbell NRC, Pons Barrera E, Calderon Martinez M, Perez Carrera A, Morales Rigau JM, et al. Implementation of a community-based hypertension control program in Matanzas, Cuba. J Clin Hypertens (Greenwich). 2020;22(2):142\u20139.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"2824_CR12","doi-asserted-by":"publisher","first-page":"e11259","DOI":"10.1016\/j.heliyon.2022.e11259","volume":"8","author":"A Wattanapisit","year":"2022","unstructured":"Wattanapisit A, Ng CJ, Angkurawaranon C, Wattanapisit S, Chaovalit S, Stoutenberg M. Summary and application of the WHO 2020 physical activity guidelines for patients with essential hypertension in primary care. Heliyon. 2022;8(10):e11259.","journal-title":"Heliyon"},{"key":"2824_CR13","unstructured":"Thai Hypertension Society. Thai Guidelines on The Treatment of Hypertension update 2019 2019 [Available from: http:\/\/www.thaiheart.org\/images\/column_1563846428\/Thai HT Guideline 2019.pdf"},{"issue":"8","key":"2824_CR14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1177\/10105395211008754","volume":"33","author":"P Chattranukulchai","year":"2021","unstructured":"Chattranukulchai P, Thongtang N, Ophascharoensuk V, Muengtaweepongsa S, Angkurawaranon C, Chalom K, et al. An implementation framework for telemedicine to address noncommunicable diseases in Thailand. Asia Pac J Public Health. 2021;33(8):968\u201371.","journal-title":"Asia Pac J Public Health"},{"issue":"1","key":"2824_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.35755\/jmedassocthai.2023.01.13737","volume":"106","author":"P Chattranukulchai","year":"2023","unstructured":"Chattranukulchai P, Thongtang N, Kunanon S, Roubsanthisuk W, Angkurawaranon C, Leetongin G, et al. Implementing the implementation framework for telemedicine to address Non-Communicable diseases in Thailand: what we have learned. J Med Assoc Thai. 2023;106(1):102\u20135.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"2824_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12875-020-01183-0","volume":"21","author":"N Buawangpong","year":"2020","unstructured":"Buawangpong N, Pinyopornpanish K, Jiraporncharoen W, Dejkriengkraikul N, Sagulkoo P, Pateekhum C, et al. Incorporating the patient-centered approach into clinical practice helps improve quality of care in cases of hypertension: a retrospective cohort study. BMC Fam Pract. 2020;21(1):108.","journal-title":"BMC Fam Pract"},{"key":"2824_CR17","unstructured":"RTI International, Centers for Disease Control and Prevention (CDC). World health organization (WHO). The global HEARTS costing tool. Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET); 2022."},{"issue":"6","key":"2824_CR18","doi-asserted-by":"publisher","first-page":"e061467","DOI":"10.1136\/bmjopen-2022-061467","volume":"12","author":"MJ Husain","year":"2022","unstructured":"Husain MJ, Haider MS, Tarannum R, Jubayer S, Bhuiyan MR, Kostova D, et al. Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application. BMJ Open. 2022;12(6):e061467.","journal-title":"BMJ Open"},{"key":"2824_CR19","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.26633\/RPSP.2022.144","volume":"46","author":"C Chivardi","year":"2022","unstructured":"Chivardi C, Hutchinson B, Molina V, Moreno E, Fajardo I, Giraldo-Arcila GP, et al. Assessing costs of a hypertension program in primary care: evidence from the HEARTS program in Mexico. Rev Panam Salud Publica. 2022;46:e144.","journal-title":"Rev Panam Salud Publica"},{"key":"2824_CR20","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.26633\/RPSP.2022.140","volume":"46","author":"AE Moran","year":"2022","unstructured":"Moran AE, Farrell M, Cazabon D, Sahoo SK, Mugrditchian D, Pidugu A, et al. Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries. Rev Panam Salud Publica. 2022;46:e140.","journal-title":"Rev Panam Salud Publica"},{"key":"2824_CR21","unstructured":"The 43 folders National Health Database. Health Data Center (HDC)."},{"issue":"10","key":"2824_CR22","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.35755\/jmedassocthai.2021.10.12199","volume":"104","author":"SCP Kunanon","year":"2021","unstructured":"Kunanon SCP, Chotruangnapa C, Kositanurit W, Methavigul K, Boonyasirinant T, Rawdaree P, et al. 2019 Thai guidelines on the treatment of hypertension: executive summary. J Med Assoc Thai. 2021;104(10):1729\u201338.","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"2824_CR23","first-page":"12","volume":"25","author":"W Techakehakij","year":"2016","unstructured":"Techakehakij W. Cost-Outcome analysis of hypertension treatment at the Out-Patient department: a comparison across public health insurance schemes. J Health Sci. 2016;25(2):12.","journal-title":"J Health Sci"},{"issue":"2","key":"2824_CR24","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/HYPERTENSIONAHA.120.15781","volume":"77","author":"G Parati","year":"2021","unstructured":"Parati G, Kjeldsen S, Coca A, Cushman WC, Wang J. Adherence to Single-Pill versus Free-Equivalent combination therapy in hypertension: A systematic review and Meta-Analysis. Hypertension. 2021;77(2):692\u2013705.","journal-title":"Hypertension"},{"issue":"12","key":"2824_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1093\/qjmed\/hci139","volume":"98","author":"B Williams","year":"2005","unstructured":"Williams B, Shaw A, Durrant R, Crinson I, Pagliari C, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM. 2005;98(12):885\u201393.","journal-title":"QJM"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-025-02824-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-025-02824-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T07:16:14Z","timestamp":1745392574000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-025-02824-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2824"],"URL":"https:\/\/doi.org\/10.1186\/s12875-025-02824-y","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"22 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, and received ethical approval from the Faculty of Medicine, Chiang Mai University (No 426\/2020 and No. 077\/2022). The research protocol was reviewed, and concerns were addressed before data collection. Informed consent was obtained from participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"120"}}